- CIIX
recently became the first Chinese company to sell CBD products in the
United States
- The
company launched a pop-up kiosk in the Glendale Galleria Mall to sell
industrial hemp/CBD products
- CIIX
recorded an 80 percent YOY increase in Q3 fiscal 2019 sales numbers
ChineseInvestors.com
Inc. (OTCQB: CIIX), having established itself as a leading financial
information website for Chinese-speaking investors in the United States and
China, recognized unprecedented opportunities in the U.S. cannabis industry.
Seeing that opportunity, CIIX began laying the groundwork to capitalize on the
growing demand for cannabidiol (CBD)-based nutrition and health products. In
doing so, CIIX became the first Chinese company to sell CBD products in the
United States.
The company’s wholly owned subsidiary, ChineseHempOil.com
Inc., has been doing business as Chinese Wellness Center (“CWC”) in the United
States since 2017. The company specializes in the promotion and sales of
high-end nutritional supplements and CBD hemp oil.
In a recent press release (http://ibn.fm/EaSpz), CIIX announced the launch of a pop-up
mall kiosk in Glendale, California, through CWC. The kiosk began selling
industrial hemp/CBD products on May 1, 2019. Products being offered include
CWC’s own OptHemp product line, as well as NuLeaf Naturals, Joy Organics,
Medterra, Hemp Meds and Medix.
“We are excited to bring our brand directly to the shoppers
in the Greater Los Angeles area,” CIIX CEO Warren Wang stated in a news
release. “Building on the current success of CWC’s industrial hemp/CBD product
offerings, this pop-up kiosk will allow us to further engage with our local
consumers beyond our online presence.”
CIIX is dedicated to the education of its customers and
offers only the best products and solutions as it continues to expand its reach
and educational awareness to the Chinese-speaking community. The company’s
vision for excellence, along with its ability to identify and act on
value-enhancing opportunities while providing the highest quality service to
accommodate consumers’ needs, is what drives CIIX’s success.
For the third quarter of fiscal 2019, the company reported
record revenues. An 81 percent year-over-year gain, totaling $1,444,822 in
revenues, was attributed to a large increase in industrial hemp and CBD product
sales.
“Our financial performance and highlights for the quarter
are a testament to the popularity and demand for our CBD and hemp products,”
Wang stated in a news release (http://ibn.fm/uzsTb). “As a result, we continue to make
significant progress in our business through our investments intended to grow
the platform for our consumer product lines.”
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment